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Abstract
Background: The interaction of human T-cell leukemia virus type 1 (HTLV-1) Tax1 protein with
the tumor suppressor Dlg1 is correlated with cellular transformation.
Results: Here, we show that Dlg1 knockdown by RNA interference increases the ability of Tax1
to transform a mouse T-cell line (CTLL-2), as measured interleukin (IL)-2-independent growth. A
Tax1 mutant defective for the Dlg1 interaction showed reduced transformation of CTLL-2
compared to wild type Tax1, but the transformation was minimally affected by Dlg1 reduction. The
few Tax1ΔC-transduced CTLL-2 cells that became transformed expressed less Dlg1 than parental
cells, suggesting that Dlg1-low cells were selectively transformed by Tax1ΔC. Moreover, all human
T-cell lines immortalized by HTLV-1, including the recombinant HTLV-1-containing Tax1ΔC,
expressed less Dlg1 than control T-cell lines.
Conclusion:  These results suggest that inactivation of Dlg1 augments Tax1-mediated
transformation of CTLL-2, and PDZ protein(s) other than Dlg1 are critically involved in the
transformation.
Background
Adult T-cell leukemia (ATL) is an aggressive leukemia that
originates mostly from CD4+ T-cells [1-3]. Human T-cell
leukemia virus type 1 (HTLV-1) is a causative retrovirus of
ATL [4,5]. HTLV-1 immortalizes human CD4+ T-cells in
vitro and probably does so in vivo, but such immortaliza-
tion is not sufficient for the development of ATL, since
only 3–5% of HTLV-1 infection causes ATL after long-
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latent period of 60–70 years [1-3,6,7]. Multiple genetic
and epigenetic changes in HTLV-1-infected cells and dete-
rioration of host immune system during the latent period,
are thought to be prerequisite for the development of ATL
[3].
HTLV-1 Tax1 is a key player, involved in both T-cell
immortalization as well as the leukemogenesis, and it
shows transforming activities in various systems [8,9].
Transduction of the tax1  gene into peripheral blood
mononuclear cells using viral vectors induces inter-
leukin(IL)-2-dependent immortalization of CD4+ T-cells
in vitro [10,11]. In vivo, Tax1-transgenic animals develop
various tumors including pre-T-cell leukemia [12-14].
Tax1 also perturbs cellular gene expression, in part,
through activation of transcription factors such as NF-κB,
serum response factor, and AP-1, thereby inducing the
expression of genes encoding cytokines, cytokine recep-
tors, chemokines, and anti-apoptotic factors [8,15-20].
HTLV Type 2 (HTLV-2) is a retrovirus that is similar in
many respects to HTLV-1 [21]. For instance, HTLV-2
establishes life-long persistent infection in humans and
immortalizes human T-cells in an efficiency equivalent to
HTLV-1 in vitro. Interestingly, HTLV-2 is not, associated
with ATL or related malignancies and has been associated
with only a few cases of lymphoproliferative disorders.
Recent evidence suggested that the PDZ protein binding
motif (PBM) at the C-terminus of Tax1, which is missing
in HTLV-2 Tax2, plays a crucial role in the distinct patho-
genesis between HTLV-1 and HTLV-2 [8,21-25]. For
instance, the transforming ability of Tax1 is much greater
than Tax2 in a mouse T-cell line (CTLL-2), and this differ-
ence appears to be determined by the PBM [23,25]. A
recombinant HTLV-1 with a deletion of the PBM (HTLV-
1ΔPBM) failed to establish persistent infection in rabbits,
as measured by the lack of antibody responses against
HTLV-1 and the absence of HTLV-1 proviruses [24]. Inter-
estingly, HTLV-1ΔPBM can transform human T-cells,
although in a less efficient manner than the wild type
virus, suggesting that the Tax1 PBM is essential for persist-
ent infection in vivo, but dispensable for the transforma-
tion of human T-cells.
The PBM of HTLV-1 Tax1 interacts with several PDZ pro-
teins such as Dlg1, the precursor of IL-16, and MAGI-3
[23,26-30]. Among these, Dlg1 is an attractive candidate
associated with the transforming activity of Tax1. Dlg orig-
inally was isolated from Drosophila and was shown to be
a tumor suppressor gene. Loss-of-function mutations in
Dlg1 in Drosophila resulted in the neoplastic overgrowth
of imaginal disc epithelial cells [31]. Dlg1 also is a tumor
suppressor gene in mice, such that Dlg1 heterozygous
mice develop B-cell or NK cell lymphomas [32]. Moreo-
ver, over-expression of Dlg1 induced cell cycle arrest of a
mouse fibroblast cell line NIH3T3, and the arrest was res-
cued by Tax1 in a PBM-dependent manner [28].
CTLL-2 is a mouse T-cell line, the growth of which is
dependent on IL-2. We previously showed that Tax1 abro-
gates the IL-2-dependent growth phenotype of CTLL-2
[33]. Whereas expression of Tax1 often induces cell
growth arrest [34], CTLL-2 is resistant to such Tax1 activ-
ity, thereby being a useful tool to examine the transform-
ing activity of Tax1 toward T-cells. In the study reported
here, knockdown of D1g1 with RNA interference (RNAi)
enhanced the ability of Tax1 to induce IL-2 independence
in CTLL-2 cells. Moreover, Dlg1 expression was signifi-
cantly less in all HTLV-1-transformed T-cell lines com-
pared to HTLV-1-negative cell lines, suggesting that
inactivation of Dlg1 is a critical step for transforming
activity of Tax1. We will discuss these findings in the con-
text of T-cell transformation by HTLV-1.
Results
Dlg1 knockdown augments the ability of Tax1 to induce 
IL-2-independent growth in CTLL-2 cells
To examine the roles of Dlg1 protein in Tax1-induced IL-
2-independent growth of CTLL-2 cells, we established
CTLL-2 cells expressing reduced amount of Dlg1 using
RNA interference (RNAi). We first constructed lentivirus
vectors expressing short hairpin (sh)RNA specific to
mouse dlg1 sequences (Dlg1-1, Dlg1-3). Dlg1-1 and
Dlg1-3 target distinct sequences of mouse Dlg1 RNA. Two
control shRNAs were constructed to target bacterial chlo-
ramphenicol acetyltransferase (CAT) and renilla luciferase
(LUC) genes, both of which are not expressed normally in
mouse T-cells. These viruses were used to infect CTLL-2
cells, and the infected cells were selected by blasticidin for
more than 10 days. The established cell lines then were
examined for the expression of Dlg1 protein by Western
blotting analysis with anti-Dlg1 antibody (Figure 1). Two
Dlg1 knockdown cell lines (Dlg1-1, Dlg1-3) expressed a
reduced amount of Dlg1 protein relative to two control
cell lines (CAT, LUC). These four cell lines grew at equiv-
alent rates in the presence of IL-2 (Figure 1B), and died
without IL-2 with similar kinetics (data not shown). Thus,
the reduction of Dlg1 expression in CTLL-2 cells did not
affect apparent cell growth phenotypes. To examine the
effect of Dlg1 knockdown on Tax1-induced IL-2-inde-
pendent growth, these characterized Dlg1 knockdown cell
lines were infected with a lentivirus expressing Tax1
(Tax1-virus) and cultured in the presence of IL-2 for 48 h.
Subsequently, the cells were seeded into 96-well plates,
followed by further culturing in the absence of IL-2. After
more than two weeks, the number of wells with outgrow-
ing CTLL-2 cells was counted using a microscope. All
CTLL-2 cells infected with a control lentivirus died within
two weeks and did not induce any outgrowing cells (data
not shown). Conversely, there was an outgrowth of con-Retrovirology 2006, 3:71 http://www.retrovirology.com/content/3/1/71
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trol CTLL-2 infected with the Tax1-virus (CAT/Tax1, LUC/
Tax1) at 7–11% of wells (Figure 2). Similarly, Dlg1 knock-
down cells infected with the Tax1-virus (Dlg1-1, Dlg1-3)
also had outgrowth with three to six-folds more wells than
the controls (CAT/Tax1, LUC/Tax1). The observed differ-
ences were not due to reduced Tax1 expression in the con-
trol cells, since all four cell lines expressed equivalent
amounts of Tax1 protein after the infection as shown by
Western analysis (Figure 2A). The augmented Tax1 activity
was reproducibly observed in at least nine independent
experiments (data not shown). The Dlg1-1 and Dlg1-3
cell lines established by independent experiments also
reproduced the high sensitivity to Tax1 transformation
relative to control cells (data not shown). Taken together,
these results indicate that the reduction of Dlg1 protein in
CTLL-2 augmented the ability of Tax1 to induce IL-2 inde-
pendent growth.
Dlg1 knockdown doesn't augment Tax1ΔC activity in 
CTLL-2
We previously showed that Tax1 interacts with Dlg1
through PBM, and the deletion of PBM in Tax1 (Tax1ΔC)
greatly reduced IL-2-independent growth mediated by
Tax1 in CTLL-2 [25]. These results suggest that wild type
Tax1 inhibits the tumor suppressor-like activity of Dlg1
through direct binding via the PBM while Tax1ΔC cannot,
resulting in the reduced transforming activity. Therefore,
we examined whether Dlg1 knockdown could rescue the
transforming activity of Tax1ΔC. Tax1ΔC also induced the
outgrowth of control CTLL-2 cells (CAT), but the number
of positive wells was much less than that of Tax1, which
was consistent with the previous result [25]. It should be
noted that 1 × 105 CTLL-2 cells infected with Tax1ΔC-virus
or 3 × 102 cells with Tax1-virus were seeded per well, indi-
cating that the actual transforming activity of Tax1 versus
Tax1ΔC in CTLL-2 cells was much greater than the
observed relative difference. Tax1ΔC in the Dlg1 knock-
down cells also induced outgrowth, and the number of
positive wells was similar to that of the control cells (Fig-
ure 3B). These results suggest that inactivation of Dlg1
alone does not explain the difference in transforming
activity between Tax1 and Tax1Δ. All four IL-2-independ-
ent Tax1ΔC cell lines (Dlg1-1/Tax1ΔC, Dlg1-3/Tax1ΔC,
CAT/Tax1ΔC, LUC/Tax1ΔC) grew much more slowly than
Dlg1 knockdown in CTLL-2 does not affect the cell growth phenotypes Figure 1
Dlg1 knockdown in CTLL-2 does not affect the cell growth phenotypes. (A) CTLL-2 cells infected with lentivirus 
expressing shRNA for Dlg1-1 (lane 1), Dlg1-3 (lane 2), CAT (lane 3) and LUC (lane 4), were cultured in the presence of blasti-
cidin for more than 10 days. Cell lysates then were prepared and characterized by Western blot analysis using anti-Dlg1 anti-
body (top) or anti-Tubulin (bottom). (B) The CTLL-2 cells were cultured in the presence of IL-2 and counted by trypan blue 
exclusion method.
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the IL-2-independent Tax1 cell lines (Figure 4B), suggest-
ing that Tax1 PBM has another function in cell growth as
discussed below.
Reduced expression of Dlg1 in Tax1-transformed cells
To confirm the effect of D1g1 knockdown, we examined
the expression of Dlg1 in the cells characterized above.
Western blot analysis with anti-Dlg1 antibody demon-
strated reduced expression of Dlg1 in the Dlg1 knock-
down cells (Dlg1-1, Dlg1-3) even after IL-2-independent
transformation by Tax1 or Tax1ΔC (Figure 4A). Interest-
ingly, IL-2-independent control cells (CAT, LUC) trans-
formed either by Tax1ΔC or Tax1 expressed less Dlg1
compared to the parental non-transformed cells, and the
reduction of Dlg1 was much more prominent in Tax1ΔC
cells relative to Tax1. These results support a hypothesis
that IL-2-independent transformation of CTLL-2 cells by
Tax1ΔC requires reduction of Dlg1 expression. In the
above experiments, we used bulk (non-clonal) CTLL-2
cells transformed by Tax1ΔC or Tax1, which were estab-
lished in culture flasks. To examine this hypothesis fur-
ther, we evaluated five independent clonal CTLL-2 cell
lines transformed either by Tax1ΔC or Tax1 established in
96-well plates and compared the expression level of Dlg1
protein in these cloned cells (Fig 5). All five IL-2-inde-
pendent Tax1ΔC clones expressed reduced amounts of
Dlg1 knockdown augments IL-2-independent cell growth induced by Tax1 Figure 2
Dlg1 knockdown augments IL-2-independent cell growth induced by Tax1. (A) CTLL-2 cells were infected with a 
lentivirus encoding Tax1. Forty-eight hours after infection, cell lysates were prepared and the amount of Tax1 in the lysates 
was measured by Western blot analysis using an anti-Tax1 antibody. (B) CTLL-2 cells (Dlg1-1, Dlg1-3, CAT, LUC) infected 
with Tax1-virus were washed twice with PBS, seeded into 96-well plates at 3 × 102 cells per well, and cultured in the absence 
of IL-2 for four weeks. The number of wells containing outgrowing cells was counted under a light microscope. Transformation 
efficiency (%) was calculated as a ratio of the number of positive wells out of 96 wells. Error bars indicate standard deviations 
in three independent experiments.
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Dlg1, whereas two out of five Tax1 clones expressed Dlg1
at a level similar to Tax1ΔC. The expression of Syntrophin
β, another PDZ protein suggested to interact with Tax1
[27], was expressed equivalently in these cell lines, indi-
cating that reduced expression of Dlg1 in Tax1ΔC is spe-
cific. These data lend additional support to the hypothesis
that reduced expression of Dlg1 protein is a factor
required for Tax1ΔC-induced IL-2-independent transfor-
mation of CTLL-2 cells.
We also examined the expression of Dlg1 protein in
HTLV-1-transformed T-cell lines (Figure 6). All seven
HTLV-1-transformed T-cell lines, including one trans-
formed by HTLV-1ΔPBM with a deletion of the Tax1 PBM,
expressed lower amounts of Dlg1 than three HTLV-1 neg-
ative human T-cell lines. These results suggest that the
Dlg1-low phenotype is preferential for HTLV-1-mediated
transformation of human T-cells. The molecular weight of
Dlg1 in three HTLV-1-infected T-cell lines (ILT-Koy, SLB-
1, HUT-102) that express high amounts of Tax1 was
greater than that in HTLV-1 negative T-cell lines, which
corresponds to the phosphorylation of Dlg1 in HTLV-1-
infected T-cell lines [28]. The biological relevance of phos-
phorylated Dlg1 in HTLV-1-transformed cells is unclear
[25].
Effect of Dlg1 knockdown on Tax1 transcriptional activity
We next examined the effect of Dlg1 knockdown on Tax1
transcriptional activity. To do so, Jurkat cells were infected
with lentivirus expressing shRNA against human dlg1
Dlg1 knockdown does not augment IL-2-independent cell growth induced by Tax1ΔC Figure 3
Dlg1 knockdown does not augment IL-2-independent cell growth induced by Tax1ΔC. (A) CTLL-2 cells were 
infected with a lentivirus encoding Tax1ΔC. Forty-eight hours after infection, cell lysates were prepared and the amount of 
Tax1ΔC in the lysates was measured by Western blot analysis using an anti-Tax1 antibody. (B) CTLL-2 cells (Dlg1-1, Dlg1-3, 
CAT, LUC) infected with Tax1ΔC-virus were washed twice with PBS, seeded into 96-well plates at 5 × 103 cells per well and 
cultured in the absence of IL-2 for four weeks. The number of wells containing outgrowing cells was counted under a light 
microscope. Transformation efficiency (%) was calculated as a ratio of the number of positive wells out of 96 wells. Error bars 
indicate standard deviations in three independent experiments.
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(hDlg1). Western blotting analysis showed that two
hDlg1 knockdown cell lines (hDlg1-1, hDlg1-3)
expressed a reduced amount of Dlg1 protein relative to a
control cell line (Rluc) targeting a renilla luciferase gene
(Figure 7A). These cell lines were then transfected with a
Tax1 expression plasmid together with a firefly luciferase
reporter plasmid regulated by the NF-κB site, which acts as
a Tax1-inducible element, by the lipofection method.
Tax1 efficiently activated NF-κB -dependent luciferase
activity in two hDlg1 knockdown cells, and the activities
were equivalent to those in the control cells (Rluc, None).
These results indicates that reduction of hDlg1 protein lit-
tle affects Tax1 dependent NF-κB activation in T-cells.
Discussion
HTLV-1 Tax1 interacts with Dlg1 through PBM in various
experimental conditions as well as in HTLV-1-infected T-
cell lines, and the interaction is well correlated with trans-
forming activity of Tax1 [23,25,26,28,35]. However, it has
been unclear whether and how Dlg1 plays a role in Tax1-
mediated cellular transformation. Two lines of evidence
suggested that inactivation of Dlg1 is a critical step for the
transforming activity of Tax1, and Tax1 through PBM
inactivates inhibitory activity of Dlg1 to induce transfor-
mation of CTLL-2 cells (Figure 2). First, Dlg1 knockdown
in CTLL-2 cells increased their ability to be transformed by
Tax1 (Figure 2). Second, Tax1ΔC-transformed cells, which
Low Dlg1 expression in IL-2-independent Tax1ΔC cells Figure 4
Low Dlg1 expression in IL-2-independent Tax1ΔC cells. (A) CTLL-2 cells (Dlg1-1, Dlg1-3, CAT, LUC) were infected 
with Tax1-virus (lanes 5–8) or Tax1ΔC (lanes 9–12), and cultured in the absence of IL-2 for more than one month in culture 
flasks. Expression of Dlg1 (top), Tax1 (middle) and Tubulin (bottom) in parental IL-2-dependent CTLL-2 (lanes 1–4), Tax1-
transformed CTLL-2 (lanes 5–8) and Tax1ΔC-transformed CTLL-2 (lane 9–12), was measured by Western blot analysis. (B) 
Cells were cultured in the absence of IL-2 and counted by trypan blue staining. Data are representative of two independent 
experiments.
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were extremely rare to emerge, expressed less Dlg1 than
non-transformed cells or Tax1-transformed cells (Figure 4
and 5).
All HTLV-1-transformed T-cell lines expressed low levels
of Dlg1 relative to control T-cell lines (Figure 6). However,
it is unlikely that reduced Dlg1 expression could be due to
Tax1-induced degradation. First, unlike human papilloma
virus (HPV) E6, Tax1 expression in the kidney cell line
293T did not induce degradation of Dlg1 [23]. Moreover,
a human T-cell line transformed by recombinant HTLV-
1ΔPBM containing Tax1ΔC also possessed a low level of
Dlg1 protein (Figure 6). Taken together with the findings
in CTLL-2 cells, these results suggested that Dlg1 is an
inhibitory protein for HTLV-1-induced transformation of
human T-cells, and low-Dlg1 expression is preferential for
the HTLV-1 Tax1 function.
Dlg1 knockdown in CTLL-2 cells increased the frequency
of IL-2-independent transformation induced by Tax1 (Fig-
ure 2). Given that Tax1 through the PBM can inactivate
Dlg1 function [28], these results indicated that only cells
expressing high amounts of Tax1 or reduced amounts of
Dlg1 acquire IL-2 independent phenotype (Figure 8A and
8B). This is consistent with the observation that some
Tax1-transformed CTLL-2 cells expressed reduced
amounts of Dlg1 relative to parental CTLL-2 cells. In addi-
tion, this explains why all the human T-cells transformed
by HTLV-1 Tax1 with an intact PBM expressed relatively
low amounts of Dlg1.
Low Dlg1 expression in IL-2-independent Tax1ΔC clones Figure 5
Low Dlg1 expression in IL-2-independent Tax1ΔC clones. CTLL-2 cells were infected with Tax1-virus (lanes 1–5) or 
Tax1ΔC-virus (lanes 6–10), and seeded in 96-well plates in the absence IL-2 for more than one month. The expression of Dlg1 
(top), Syntrophin β (second column), Tax1 (third column), or Tubulin (bottom) in Tax1-transformed CTLL-2 clones (lanes 5–
8) and Tax1ΔC-transformed clones (lane 9–12), was measured by Western blot analysis using corresponding antibodies.
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It is unclear how Dlg1 inhibits the transforming activity of
Tax1 in CTLL-2 cells, and how such Dlg1 function is inac-
tivated by Tax1. Previous results showed that over-expres-
sion of Dlg1 inhibited cell cycle transition from G1 to S
phase in the mouse fibroblast cell line NIH3T3, which
was overcome by Tax1 in a PBM-dependent manner [28].
On the other hand, Tax1 changes subcellular localization
of Dlg1 from detergent soluble fraction to detergent insol-
uble fraction in HTLV-1-infected T-cell lines and 293T
cells, suggesting that Tax1 inactivates Dlg1 function
through altering the localization in cells [23]. Together,
one possible scenario is that Dlg1 inhibits cell cycle pro-
gression of CTLL-2/Tax1, but Tax1 through altering local-
ization of Dlg1 in cells, overcome the cell cycle inhibition
to initiate IL-2-independent transformation.
Dlg1 knockdown did not increase transforming activity of
Tax1ΔC toward CTLL-2 cells. This finding was initially dis-
appointing to us, since Dlg1 was a major PDZ protein
interacting with Tax1 in T-cells (data not shown). This
finding, however, suggested that PDZ protein(s) other
than Dlg1 inhibits transformation of CTLL-2 by Tax1 (Fig-
ure 8). At least two more Tax1-interacting PDZ proteins
other than Dlg1 are needed to explain the present data. As
discussed above, inactivation of one of the two PDZ pro-
teins should be essential for IL-2-independent transfor-
mation of CTLL-2 by Tax1, since Dlg1 knockdown did not
enhance the frequency of cells transformed by Tax1ΔC
(Figure 3). The other PDZ protein likely influences the
rate of proliferation of IL-2-independent Tax1 cells, since
IL-2-independent Tax1ΔC cells grew more slowly than IL-
Dlg1 expression is lower in HTLV-1-transformed human T-cell lines than HTLV-1 negative cell lines Figure 6
Dlg1 expression is lower in HTLV-1-transformed human T-cell lines than HTLV-1 negative cell lines. Cell lysates 
were prepared from seven HTLV-1 transformed T-cell lines (lanes 1–7) and three HTLV-1 negative T-cell lines (lanes 8–10). 
The expression of hDlg1 (top), Syntrophin β (second column), Tax1 (third column), or Tubulin (bottom) was measured by 
Western blot analysis using corresponding antibodies.
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2-independent Tax1 cells (Fig 4). However, it should be
noted that transformed Tax1ΔC cells exhibited more cell
death than transformed Tax1 cells (data not shown).
Thus, the latter PDZ protein might regulate apoptosis of T-
cells expressing Tax1. There are several Tax1-interacting
PDZ proteins, such as MAGI-3 and the precursor of IL-16
[30]. In addition, there are three Dlg1 family members,
such as Chapsyn-110 (PSD-93), NE-Dlg (SAP102), and
PSD-95 (SAP90) [36], although it is unclear whether they
are expressed in T-cells. Therefore, the identification of
PDZ proteins other than Dlg1 that are involved in Tax1
function is crucial to elucidate the mechanism of T-cell
transformation by HTLV-1.
Conclusion
The Tax1 PBM is conserved in all known HTLV-1 isolates
but not in HTLV-2 isolates. Similarly, the E6 oncoprotein
derived from high-risk HPVs, but not low-risk HPVs, has
a PBM and interacts with Dlg1. These results strongly sug-
gest that the PBM and the interacting protein(s) play cru-
cial roles in oncogenesis by these viruses. Approximately
12% of Dlg1 heterozygous mice developed B-cell or NK
lymphomas, which suggests that Dlg1 is involved in lym-
phomagenesis, even when its expression is half of that of
wild-type mice [32]. Thus, Dlg1 is an attractive candidate
regulating not only human T-cell transformation but also
ATL leukemogenesis.
Dlg1 knockdown little affects transcriptional activity of Tax1 Figure 7
Dlg1 knockdown little affects transcriptional activity of Tax1. (A) Cell lysates were prepared from the indicated 
knockdown cells (hDlg1-1, hDlg1-3, Rluc), and the amounts of hDlg1 protein and Tubulin in cell lysates were measured by 
Western blot analysis using anti-hDlg1 antibody (top) and anti-Tubulin (bottom), respectively. (B) Jurkat cells (hDlg1-1, hDlg1-
3, Rluc) were transfected with κ B-Luc plasmid together with pHβPr-1-Tax1-neo plasmid using the lipofection method. Forty-
eight hours after transfection, cell lysates were prepared and the luciferase activity in the lysates was measured by a luminom-
eter. Error bars indicate standard deviations.
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Materials and methods
Cells and cell growth assay
CTLL-2 is a mouse cytotoxic T-cell line that grows in an IL-
2-dependent manner [24,33]. The human T-cell lines
used in the present experiments have been characterized
previously [23]. ILT-Koy, ILT-Oot, ILT-Mat, PBL/HTLV-1,
PBL/HTLV-1ΔPBM are IL-2-dependent HTLV-1-trans-
formed human T-cell lines, while SLB-1 and HUT-102 are
IL-2-independent. PBL/HTLV-1 and PBL/HTLV-1ΔPBM
were established by recombinant wild type HTLV-1 and
HTLV-1ΔPBM with a deletion of PBM in Tax1, respectively
[24]. HUT78, MOLT-4 and Jurkat are HTLV-1-negative
human T-cell lines. 293T is a human embryonic kidney
cell line. SLB-1, HUT-102, HUT78, MOLT-4 and Jurkat
were cultured in RPMI1640 supplemented with 10% fetal
bovine serum (FBS), 4 mM glutamine, penicillin (50 U/
ml), and streptomycin (50 μg/ml) (RPMI/10%FBS).
CTLL-2 cells were cultured in RPMI/10% FBS containing
2-mercaptoethanol and 1 nM recombinant human IL-2.
IL-2-independent CTLL-2 cells stably expressing Tax1
were cultured in RPMI/10%FBS and 2-mercaptoethanol
without IL-2. IL-2-dependent human T-cell lines were cul-
tured in RPMI/20%FBS with 1 nM IL-2. 293T cells were
cultured in Dulbecco's modified Eagle's medium supple-
mented with 10% FBS, penicillin (50 U/ml), and strepto-
mycin (50 μg/ml).
For the cell growth assay, CTLL-2 (105/ml of RPMI/
10%FBS) were cultured with or without IL-2 in a 24 well
plate. The number of viable cells was counted by the
trypan blue exclusion method under a microscope.
A model of Tax1 induced transformation Figure 8
A model of Tax1 induced transformation. A) At least two PDZ proteins, Dlg1 and a putative protein X, should be inacti-
vated by Tax1 for the transformation of CTLL2 cells. B) Tax1 inactivates X more efficiently in Dlg1 knockdown cells than in 
CTLL-2 cells, resulting in the higher transformation rate. C, D) Tax1ΔC selectively transforms CTLL2 expressing low amount 
of both Dlg1 and X. In this case, cells expressing low amount of X always express low amount of Dlg1.
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Plasmids and oligonucleotides
pHβPr-1-Tax1-neo is a Tax1 expression vector, which has
a β-actin promoter and a neomycin resistance gene as a
selection marker. κB-Luc is a luciferase expression plasmid
regulated by the κB element of the IL-2 receptor κ-chain
gene and the minimal HTLV-1 promoter. The lentiviral
expression vectors, pSIN-eGFP and CS-CDF-CG-PRE,
were kindly provided by Dr. C. Boshoff (Wolfson Institute
for Biomedical Research) and Dr. H. Miyoshi (RIKEN Tsu-
kuba Institute), respectively [37]. The lentiviral expression
vector pSIN-bsrEGFP was constructed by replacing the
eGFP gene (a BamHI – NotI fragment) of pSIN-eGFP with
the bsrEGFP gene (an EcoRI – NotI fragment) from pkB-
bsrGFP [38]. eGFP and bsrEGFP genes are an enhanced
green fluorescent protein gene and a chimeric gene of
eGFP with blasticidin S deaminase, respectively. The len-
tiviral expression vector CS-CDF-CP-PRE was constructed
by replacing the eGFP gene (a NheI – XhoI fragment) of
CS-CDF-CG-PRE with a PCR amplified puromycin-N-
acetyl-transferase gene from pIRESpuro3 (Clontech).
Dlg1-1, Dlg1-3, hDlg-1, hDlg1-3, CAT, LUC, and Rluc are
oligonucleotides used for the construction of short hair-
pin (sh)RNA-expressing plasmids against mouse dlg1
sequences (nt1092-1111 and nt2391-2410), human dlg1
(hDlg1) sequences (nt2135-2153 and nt2563-2581),
chloramphenicol acetyltransferase, and renilla luciferase
genes, respectively. The sequences of these oligonucle-
otides are 5'-ggatggcgagctttaggttggGTGTGCTGTCCccaatct-
gaagcttgccatccTTTTT-3' for Dlg1-1, 5'-
ggatgtttaggagtataagttGTGTGCTGTCCaacttatgctcctgaatatc-
cTTTTT-3' for Dlg1-3, 5'-gaaagaacgagcccgattaTTCAAGA-
GAtaatcgggctcgttctttcTTTTT-3' for hDlg1-1, 5'-
gtgttcagtctgtacgagaTTCAAGAGAtctcgtacagact-
gaacacTTTTT-3' for hDlg1-3, 5'-
gagtggatgccacgacggtttGTGTGCTGTCCaaatcgtcgtggtat-
tcactcTTTTT-3' for CAT, 5'-ggcctttcactgctcctgcgaGTGTGCT-
GTCCtcgtaggagtagtgaaaggccTTTTT-3' for LUC, and 5'-
gcctttcactactcctacgTTCAAGAGAcgtaggagtagtgaaag-
gcTTTTT-3' for Rluc. The oligonucleotides Dlg1-1, Dlg1-3,
CAT, and LUC were cloned into pGEM-U6L, which has a
U6 gene promoter under the control of RNA polymerase
III. hDlg1-1, hDlg1-3, and Rluc were cloned into pSUPER,
a gift from Dr. R. Agami (The Netherlands Cancer Insti-
tute), which has a H1-RNA gene promoter. The EcoRI frag-
ments containing respective U6 promoter/shRNA or H1
promoter/shRNA sequences then were subcloned into the
EcoRI site of pSIN-bsrEGFP or CS-CDF-CP-PRE, respec-
tively.
To construct lentiviral expression plasmids for Tax1
(pSIN-EF-Tax), a DNA fragment containing the EF1α gene
promoter was amplified from pEFneo [39]. The amplified
fragment was exchanged with the SFFV promoter frag-
ment in pSIN-eGFP using EcoRI and BamHI sites (pSIN-
EF-eGFP). To utilize the Gateway recombination system
(Invitrogen), the Gateway Reading Frame Cassette A frag-
ment was inserted in the BamHI and NotI sites of pSIN-EF-
eGFP in place of eGFP (pSIN-EF-RfA). The Tax1 and
Tax1ΔC coding sequences were subcloned into pENTR/D-
TOPO (Invitrogen), and transferred to pSIN-EF-RfA by a
Gateway recombination reaction according to the manu-
facturers' instructions. The Tax1 and Tax1ΔC genes were
described previously [23].
Establishment of knockdown cells
Lentiviruses expressing shRNAs described above were pro-
duced according to a three plasmid one shot expression
system in 293T cells [40]. These lentiviruses then were
used to infect CTLL-2 or Jurkat cells (4 × 105) in a final vol-
ume of 2.0 ml RPMI/10%FBS containing 8 μg/ml of poly-
brene (Sigma) and 1 nM IL-2 for CTLL-2. The infected
CTLL-2 and Jurkat cells were cultured in the selection
medium containing 14 μg/ml of blasticidin (Invitrogen)
or 0.2 μg/ml of puromycin (Sigma) for more than 10
days, respectively. The expression of Dlg1 in the selected
cells was examined by western blotting analysis.
IL-2-independent transformation assay
CTLL-2 cells (4 × 105) were infected with lentiviruses
encoding Tax1 or Tax1ΔC in a final volume of 2.0 ml
RPMI/10%FBS containing 8 μg/ml polybrene (Sigma)
and 1 nM IL-2. At 48 hours after infection, the cells were
washed twice with phosphate-buffered saline (PBS), and
cultured in RPMI/10%FBS without IL-2. For the 96-well
plate assay, the infected CTLL-2 cells were cultured (300
cells/well/0.1 ml for Tax1 or 5000 cells/well/0.1 ml for
Tax1ΔC) without IL-2. During the culture period, the
medium was changed every three days. After four weeks,
the number of wells containing outgrowing cells was
counted under a light microscope. Transformation effi-
ciency (%) was calculated as a ratio of the number of pos-
itive wells out of 96 wells.
Western blotting
CTLL-2 cells were lysed with sodium dodecyl sulfate
(SDS)-sample buffer consisting of 62.5 mM Tris-HCl (pH
6.8), 2% SDS, 10% glycerol. Protein concentrations of the
cell lysates were measured using the DC protein assay kit
(Bio-Rad Laboratories). The cell lysates then were treated
with 50 mM DTT, 0.01% bromophenol blue and heated
at 950C for 5 min. The resultant lysates were subjected to
SDS-PAGE containing 8% acrylamide gel for Dlg1 or 10%
acrylamide for Tax1, Syntrophin β or Tubulin, and the
proteins in the gel were transferred to a nitrocellulose
membrane. The membrane was incubated with 5% skim
milk for 1 h at room temperature followed by incubation
with specific antibodies shown below. After washing, the
membrane was treated with a secondary antibody conju-
gated with horseradish peroxidase. Specific protein bands
were visualized using the ECL Western blotting detectionRetrovirology 2006, 3:71 http://www.retrovirology.com/content/3/1/71
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system (Amersham Pharmacia Biotech). Antibodies used
were anti-human Dlg1 (BD Biosciences), anti-Tax1
(TAXY-7) [41], anti-Syntrophin β (Affinity Bioreagents),
and anti-Tubulin (Oncogene).
Transient transfection and luciferase assays
Jurkat cells in RPMI/10%FBS were seeded at 4 × 105 cells/
well in a 12-well plate. The cells then were cotransfected
with the Tax expression plasmid together with κB-Luc by
using Transfectin (Bio-Rad Laboratories) according to the
manufacturer's instructions. At 48 hours after transfec-
tion, cell lysates were prepared from the transfected cells,
and the luciferase activity was determined using Luciferase
Assay System (Promega) and a luminometer (LUMAT
LB9507, Berthold).
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